Skip to main content
Business Law 3% exam weight

Consumer Protection Act & Patient Rights

Part of the SAPC (South Africa) study roadmap. Business Law topic busine-006 of Business Law.

→ See in Roadmap Build 1-Month Plan

Consumer Protection Act & Patient Rights

🟢 Lite — Quick Review (1h–1d)

Rapid summary for last-minute revision before your exam.

Consumer Protection Act & Patient Rights — Key Facts for SAPC (South Africa) Core concept: The Consumer Protection Act 68 of 2008 (CPA) is landmark legislation that establishes the rights of consumers in their dealings with suppliers of goods and services, including pharmaceutical services. In the pharmacy context, the CPA imposes obligations on pharmacists and pharmacies regarding safe medicines, adequate information disclosure, fair pricing, and the right of patients to voice complaints. These obligations operate alongside and complement the constitutional rights to healthcare, bodily integrity, and access to information. High-yield point: Under Section 61 of the CPA, the entire supply chain — including the pharmacy — is potentially liable to a patient for harm caused by unsafe or defective medicines. This liability is joint and several, meaning a patient may claim against the pharmacy alone without first pursuing the manufacturer or wholesaler. Pharmacists must therefore ensure they can demonstrate that medicines were sourced from licensed suppliers and stored correctly, as these are key defences against CPA liability. ⚡ Exam tip: The CPA is frequently examined in conjunction with the Pharmacy Act and constitutional rights. When answering scenario questions, ask: Does this scenario engage patient rights under the Constitution? Does the CPA apply? Are the SAPC’s professional standards met? An excellent answer will address all three dimensions simultaneously.

🟡 Standard — Regular Study (2d–2mo)

Standard content for students with a few days to months.

Consumer Protection Act & Patient Rights — SAPC (South Africa) Study Guide Overview: The Consumer Protection Act 68 of 2008 (CPA) is one of the most significant pieces of consumer legislation in South African law. It came into full operation in 2011 and fundamentally reshaped the relationship between consumers and suppliers of goods and services. For pharmacy students, understanding the CPA is essential because every dispensing transaction — every time a pharmacist supplies a medicine to a patient — is a consumer transaction to which the CPA applies. The CPA creates rights that patients can assert against pharmacies, duties that pharmacies must discharge, and mechanisms for enforcement that operate alongside the SAPC’s professional regulatory framework. In addition, the constitutional rights enshrined in the Bill of Rights (particularly Sections 12, 27, and 32) inform and sometimes amplify the rights created by the CPA. Core principles: The CPA defines a consumer as any person who is the ultimate user of goods or services, and a supplier as any person who supplies goods or services in the ordinary course of business. Pharmacies are suppliers; patients are consumers. The CPA creates a comprehensive framework of consumer rights, including: the right to privacy; the right to fair and honest dealing; the right to fair, reasonable, and just pricing; the right to choice; the right to disclosure of information; the right to safety from unsafe goods; and the right to claim compensation for harm caused by goods or services. These rights cannot be excluded by contract. The CPA also imposes obligations on suppliers to ensure the safety and quality of goods supplied, to disclose material information, and to avoid unconscionable conduct. Key points:

  • The right to safe, quality goods (Sections 20, 23, 24): Medicines supplied by a pharmacy must be safe for their intended use and must be of merchantable quality. The implied warranty that goods are safe and free from defects cannot be excluded. If a medicine is found to be defective after dispensing — for example, if particulate matter is discovered in an injectable medicine — the patient who received it may have a claim under the CPA even if the pharmacy was unaware of the defect at the time of dispensing.
  • The right to fair, reasonable, and just pricing (Section 56): The CPA protects consumers against unfair, unreasonable, or unjust prices. In pharmacy, this is relevant to the display of dispensing fees, the pricing of Schedule 0 and Schedule 1 medicines, and the information provided to patients about the total cost of their medication. Prices must be displayed or made available to consumers before the transaction is concluded. A pharmacy that materially misleads a patient about the cost of their medication may be in violation of the CPA’s pricing provisions.
  • The right to information disclosure (Sections 22, 23, 36): Suppliers must disclose all material information about goods and services before the transaction is concluded. For pharmacy, this includes: the name and registration number of the medicine (both the trade name and the generic active ingredient); the correct dosage and instructions for use; any known side effects; the expiry date; storage requirements; and any relevant warnings. This information must be communicated in plain language that the patient can understand.
  • The right to fair and honest dealing (Sections 40, 41): Suppliers may not engage in unconscionable conduct, false or misleading representations, or conduct that exploits a consumer’s vulnerability. In pharmacy, this is relevant to how pharmacy staff present product alternatives, the information provided about generic versus brand-name medicines, and whether patients are pressured into purchasing additional products during dispensing.
  • Section 61 — Chain liability: Section 61 of the CPA creates joint and several liability along the supply chain for harm caused by unsafe or defective goods. The manufacturer is strictly liable (no negligence required). The importer is liable if the harm was caused by goods that were imported. The distributor and wholesaler are liable if they were part of the chain of distribution. The pharmacy is liable as the retailer if the goods were supplied to the consumer through it. This means a patient who is harmed by a defective medicine can sue the pharmacy directly, without first suing the manufacturer or wholesaler. The pharmacy then has a right of contribution against other parties in the chain.
  • Patient rights and the Constitution: The constitutional rights to bodily integrity (Section 12), healthcare services (Section 27), and access to information (Section 32) interact with the CPA to create a comprehensive patient rights framework. The right to bodily integrity means that patients must give informed consent before receiving treatment or medicines. The right to access healthcare means that pharmacies cannot refuse to dispense lawful prescriptions without lawful cause. The right to access information means that patients are entitled to full information about their treatment and the medicines they are receiving.
  • Complaints and remedies under the CPA: A patient who believes their CPA rights have been violated may complain directly to the pharmacy, to the SAPC, to the National Consumer Commission (NCC), or to the courts. The NCC is the primary enforcement body for the CPA. It can investigate complaints, issue compliance notices, impose administrative penalties, and refer matters for prosecution. Courts can grant interdictory relief, ordering the pharmacy to stop conduct that violates the CPA, and can award damages for losses suffered. Study strategy: Map the CPA’s consumer rights to their pharmacy practice equivalents. For each consumer right, identify the corresponding pharmacy obligation. Pay particular attention to the interaction between the CPA and the SAPC’s professional standards — a pharmacist who complies with SAPC Rules regarding patient counselling and information provision will generally satisfy many CPA disclosure obligations, but additional CPA-specific requirements (such as the requirement to provide pricing information before concluding the transaction) may exist even where SAPC Rules are silent.

🔴 Extended — Deep Study (3mo+)

Comprehensive coverage for students on a longer study timeline.

Consumer Protection Act & Patient Rights — Comprehensive SAPC (South Africa) Notes Full coverage: This topic provides comprehensive coverage of the Consumer Protection Act 68 of 2008 and its application to pharmacy practice in South Africa, including the full catalogue of consumer rights, supplier obligations, the Section 61 chain liability framework, enforcement mechanisms, the interaction with constitutional rights, and the overlap between the CPA framework and the SAPC’s professional regulatory system. Understanding the CPA’s patient rights framework is essential for every practising pharmacist, as it defines the legal baseline below which no pharmacy practice may fall, regardless of what the SAPC’s professional standards say.

1. The Purpose and Scope of the Consumer Protection Act

The Consumer Protection Act 68 of 2008 was enacted to promote and protect the interests of consumers in South Africa. Its stated purposes include: providing a consistent, transparent, and accessible framework for consumer transactions; protecting consumers from unfair market practices; promoting consumer confidence and the participation of consumers in the market; and providing accessible mechanisms for the resolution of consumer disputes. The CPA is given effect by the Department of Trade, Industry and Competition (previously the Department of Trade and Industry) and is administered by the National Consumer Commission (NCC), established under Section 85 of the CPA. The CPA applies to all consumer transactions, defined as transactions in which a supplier supplies goods or services to a consumer in the ordinary course of the supplier’s business, for consideration. There is no monetary threshold below which the CPA does not apply — even small transactions are covered. The CPA also applies regardless of whether the consumer is a natural person or a juristic person, though certain protections are more relevant to natural persons (such as the right to privacy and the prohibition on unconscionable conduct).

2. Consumer Rights in Detail

The CPA creates a comprehensive catalogue of consumer rights. Each right has specific implications for pharmacy practice.

The right to privacy (Section 11): Consumers have the right to restrict the receipt of unwanted marketing communications and to have their personal information protected. In pharmacy, this right is relevant to the use of patient medication records, the sending of marketing communications about promotions or new products, and the sharing of patient information with third parties such as medical aid schemes. Pharmacies must have a privacy policy that explains how patient information is collected, used, stored, and shared, and must obtain appropriate consent for any use beyond the primary dispensing purpose.

The right to fair and honest dealing (Sections 40–41): Suppliers must deal fairly and honestly with consumers and may not engage in unconscionable conduct, false representations, or conduct that exploits the consumer’s ignorance or vulnerability. In pharmacy, this is particularly relevant to: the substitution of generic medicines (which is regulated under the Medicines Act but must also comply with the CPA’s prohibition on misleading representations); the recommendation of additional products during dispensing (pharmacy staff must not pressure patients to purchase products they do not need or that are not in their best interests); and the accuracy of claims made about the efficacy or suitability of products.

The right to fair, reasonable, and just pricing (Section 56): Consumers have the right to prices that are fair, reasonable, and just. The CPA prohibits suppliers from charging excessive prices that exploit consumers, though what constitutes an excessive price is determined by reference to prevailing market prices, the supplier’s cost structure, and comparable goods or services. In pharmacy, this right is most relevant to: dispensing fee transparency — patients must be informed of the dispensing fee before or at the time of dispensing; the pricing of Schedule 0 and Schedule 1 medicines sold over the counter; and the pricing of pharmacy services such as medication counselling, blood pressure measurement, or glucose testing, where these are charged for separately.

The right to fair, reasonable, and adequate services (Section 54): Consumers have the right to services that are of fair and reasonable quality and that are performed in a fair and reasonable manner. In pharmacy, this right is engaged by the professional dispensing service itself. The standard of the dispensing service must meet professional standards as determined by the SAPC. A dispensing service that falls below the professional standard — for example, a dispensing process in which the pharmacist does not check the patient’s history, does not counsel the patient, and dispenses medicine without adequate verification — may be in breach of the CPA’s service quality standards even if no harm results.

The right to disclosure of information (Sections 22–24): Suppliers must disclose all material information about goods and services before the transaction is concluded. Information must be in plain language and must be adequate to enable the consumer to make an informed decision. In pharmacy, the information that must be disclosed includes: the name of the medicine (trade name and generic active ingredient where applicable); the purpose for which the medicine is intended; instructions for use; dosage; side effects; contraindications; storage conditions; expiry date; and any relevant warnings. The SAPC’s Rules Relating to Pharmacy require patient counselling and information provision — these requirements overlap substantially with the CPA’s disclosure obligations, and compliance with SAPC Rules will generally satisfy the CPA’s information disclosure requirements.

The right to safety from unsafe or defective goods (Sections 20, 23): This is the right most directly engaged in the pharmaceutical supply chain context. Every consumer has the right to receive goods that are safe and free from defects. This right is supplemented by the implied warranty that goods are safe, of good quality, and fit for their intended purpose (Section 20). The warranty cannot be excluded. In pharmacy, this means that a pharmacy must not supply a medicine that is past its expiry date, that has been stored outside required temperature conditions, that has damaged packaging, or that is otherwise defective. Such supply would constitute a breach of the implied warranty and the CPA’s safety right.

The right to claim compensation for harm caused by goods (Section 61): This is the CPA’s most significant liability provision. Section 61(1) provides that a producer, importer, distributor, or retailer of any goods is liable for the harm caused to a consumer by those goods if: the goods were unsafe; the goods had a defect that caused harm; or the goods were insufficiently safe or reliable. The liability under Section 61 is strict — no finding of negligence is required. The defendant is liable if the goods were unsafe, defective, or inadequate, and the consumer suffered harm as a result. This is distinct from the common law delictual claim, which requires proof of negligence. Section 61(4) provides that the liability is joint and several — each party in the supply chain may be held liable for the full amount of the harm, with a right of contribution against other parties.

3. Joint and Several Liability Under Section 61

The joint and several liability provision in Section 61 of the CPA has profound implications for pharmacy. It means that a patient who suffers harm from a defective medicine does not need to identify which party in the supply chain was at fault — they can sue the pharmacy (the retailer) directly, and the pharmacy will be liable for the full harm unless it can establish that the defect was not present when the goods were supplied to the consumer.

To defend a Section 61 claim, a pharmacy must be able to demonstrate: that the goods were sourced from a licensed and reputable SAHPRA-licensed wholesaler; that the goods were stored and handled in accordance with the required storage conditions; that the goods were checked on receipt and before dispensing; that no defect was apparent upon reasonable inspection; and that the pharmacy took all reasonable steps to ensure the safety of the goods supplied. This is essentially a due diligence defence — the pharmacy is arguing that it did everything reasonably possible to ensure the goods were safe, and the defect must have arisen upstream in the supply chain.

Pharmacies should maintain the following records as a matter of routine to support this due diligence defence: temperature monitoring records for cold chain products; records of receipt checks confirming integrity of packaging and absence of visible defects; records of batch numbers and expiry dates; records confirming the SAHPRA licence status of the supplier at the time of purchase; and any customer complaint records relating to the quality of specific batches of medicines. These records are not merely good practice — they are essential evidence in potential CPA litigation.

4. Patient Rights and the Constitution

The CPA operates in a constitutional context. The Constitution of the Republic of South Africa, 1996, establishes fundamental rights that interact with and in some cases amplify the rights created by the CPA. The most relevant constitutional rights for pharmacy patients are:

The right to bodily integrity (Section 12): Section 12(2) guarantees every person the right to bodily integrity, including the right to security in and control over their body. In the pharmacy context, this right underpins the requirement of informed consent — a patient has the right to be fully informed about and to consent to any medical treatment or medicine before receiving it. A pharmacist who administers a medicine or vaccine without the patient’s informed consent may be liable for infringement of the patient’s bodily integrity right, in addition to any professional misconduct charge before the SAPC.

The right to access healthcare services (Section 27): Section 27(1)(a) guarantees every person the right to access healthcare services. This right imposes an obligation on the state to take reasonable measures to achieve the progressive realisation of this right, but it also has implications for private pharmacists. A pharmacy that refuses to dispense a lawful prescription without lawful cause may be engaging in conduct that impedes the patient’s access to healthcare services. While a pharmacist has professional and ethical rights to conscientious objection in certain circumstances (for example, refusing to dispense an abortion-related medicine on moral or religious grounds), that right must be exercised within the framework of the SAPC’s ethical rules and must not result in the patient being left without access to a lawful service.

The right to access information (Section 32): Section 32 guarantees the right to access information held by the state or by another person that is required for the exercise or protection of any right. In pharmacy, this right is relevant to patients accessing their own medication records, prescription history, and the information held by the pharmacy about their health. A pharmacy that refuses to provide a patient with access to their own records may be in violation of Section 32, in addition to any SAPC Rule requiring the maintenance and disclosure of patient records.

The right to just administrative action (Section 33): This right, given effect by the Promotion of Administrative Justice Act 3 of 2000, is relevant when an administrative body such as the SAPC, SAHPRA, or a provincial health department makes a decision affecting a pharmacist’s or patient’s rights. Patients who are aggrieved by decisions of these bodies (for example, SAHPRA’s refusal to register a medicine, or the SAPC’s decision to cancel a pharmacy’s registration) may invoke the right to just administrative action.

5. Overlap Between the CPA and the SAPC Framework

The CPA and the SAPC’s professional regulatory framework operate in parallel but distinct spheres, and they overlap substantially in practice. The SAPC’s Rules Relating to Pharmacy impose professional standards on pharmacists in areas such as patient counselling, record-keeping, dispensing procedures, and handling of patient queries. These professional standards are informed by and consistent with the CPA’s consumer rights obligations. A pharmacist who follows SAPC Rules will generally satisfy the corresponding CPA obligations. However, there are areas where the CPA imposes obligations that are not fully addressed by SAPC Rules, and pharmacists must be aware of these.

Specific areas of overlap and distinction include:

  • Patient counselling: SAPC Rules require that patients receiving new prescriptions or medicines they have not previously used must be counselled by a pharmacist. The CPA’s disclosure of information right requires that patients receive adequate information about the medicines they are dispensed. These overlap substantially.
  • Pricing: SAPC Rules do not specifically regulate the display of prices for Schedule 0 and Schedule 1 medicines sold without a prescription. The CPA requires that prices be disclosed before the transaction is concluded. Pharmacies must therefore display prices for OTC medicines in accordance with the CPA.
  • Complaints handling: SAPC Rules require pharmacies to have complaints handling procedures. The CPA requires that suppliers inform consumers of the procedure for making complaints and the complaint handling mechanisms available. Pharmacies must ensure their complaints procedures are accessible, well-publicised, and effective.
  • Privacy of patient information: The CPA’s privacy rights and the constitutional right to privacy both apply to patient medication records. The Protection of Personal Information Act 4 of 2013 (POPIA) provides a more detailed framework for the protection of personal information, including health information, which is highly relevant to pharmacy records. Pharmacies must comply with both POPIA and the CPA’s privacy provisions.

6. Enforcement Mechanisms and Remedies

The CPA provides multiple enforcement mechanisms. The National Consumer Commission (NCC) is the primary enforcement agency. It can investigate complaints, issue compliance notices (requiring a supplier to cease or remedy conduct that contravenes the CPA), impose administrative penalties of up to R1 million for a first contravention (with higher penalties for subsequent contraventions), refer matters for criminal prosecution, and seek interdictory relief from courts.

Consumers can also enforce their CPA rights directly through the courts. A patient who believes their rights have been violated can approach the courts for relief, including interdictory relief (ordering the pharmacy to stop or do something), specific performance (ordering the pharmacy to do something it ought to have done), and damages (monetary compensation for losses suffered). In practice, most CPA complaints are first referred to the NCC, which attempts conciliation before taking enforcement action, but the courts remain available for urgent matters.

The SAPC also provides a parallel enforcement mechanism for professional conduct matters. A pharmacist who violates the CPA in the course of professional practice may face a complaint before the SAPC’s Investigating Committee and, if found guilty of unprofessional conduct, disciplinary sanctions. The SAPC has its own Rules Relating to Pharmacy that address many of the same conduct issues as the CPA, and the SAPC’s disciplinary process may be invoked concurrently with CPA enforcement by the NCC.

7. Problem-Solving Strategies and Common Mistakes

When approaching questions on the CPA and patient rights in pharmacy examinations, always begin by identifying whether the patient is a consumer within the meaning of the CPA, whether the pharmacy is a supplier within the meaning of the CPA, and whether the transaction falls within the ordinary course of the pharmacy’s business. If all three are satisfied, the CPA applies. Then identify which specific consumer rights are engaged and what obligations the pharmacy owes as a result. Assess whether the pharmacy has discharged those obligations, and if not, identify what remedies are available to the patient and what liability the pharmacy faces. Finally, consider the constitutional overlay — does the scenario engage any constitutional rights? If so, the constitutional provision may inform the interpretation of the CPA obligation.

Common mistakes to avoid: assuming the CPA applies only to consumer transactions above a certain monetary value; conflating the CPA’s consumer rights with the SAPC’s professional standards (they are distinct frameworks operating in parallel); failing to appreciate the strict nature of Section 61 liability (no negligence need be proven — mere proof that the goods were unsafe is sufficient); overlooking POPIA as the primary privacy legislation applicable to patient records (POPIA, not the CPA, is the primary framework for information privacy in South Africa); and neglecting to consider that the SAPC disciplinary process and the CPA enforcement mechanisms may operate concurrently.

Practice: Analyse past SAPC examination questions that involve patient rights, pharmacy complaints, medicine defects, and consumer protection issues. For each, map the applicable CPA provisions, assess the pharmacy’s compliance obligations, and identify the remedies available to the patient and the consequences for the pharmacy.

Content adapted based on your selected roadmap duration. Switch tiers using the selector above.